Chengda Pharmaceuticals Co (SZSE:301201) Net Change in Cash : ¥-934.4 Mil (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Chengda Pharmaceuticals Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Chengda Pharmaceuticals Co's Net Change in Cash for the three months ended in Sep. 2024 was ¥-463.3 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-934.4 Mil.

Chengda Pharmaceuticals Co Net Change in Cash Historical Data

The historical data trend for Chengda Pharmaceuticals Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengda Pharmaceuticals Co Net Change in Cash Chart

Chengda Pharmaceuticals Co Annual Data

Trend

Dec08

Dec09

Dec10

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

38.43

-14.92

-28.52

585.94

758.26

Chengda Pharmaceuticals Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Change in Cash	Get a 7-Day Free Trial															26.73	-49.16	-161.04	-260.89	-463.26

Chengda Pharmaceuticals Co Net Change in Cash Calculation

Chengda Pharmaceuticals Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	192.072	+	594.391	+	-29.009	+	0.804
	=	758.3

Chengda Pharmaceuticals Co's Net Change in Cash for the quarter that ended in Sep. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 11.208 + -444.118 + -30.502 + 0.149

= -463.3

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-934.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chengda Pharmaceuticals Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Chengda Pharmaceuticals Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Chengda Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chengda Pharmaceuticals Co Ltd (SZSE:301201) » Definitions » Net Change in Cash

Comparable Companies

SZSE:002900 SHSE:603538 SHSE:603669 SZSE:300636 SZSE:300239 SZSE:002412 SHSE:688117 SHSE:600222 SZSE:300683 SZSE:300016 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA

Traded in Other Exchanges

N/A

Address

36 Huanghe Road, Huimin Street, Jiashan County, Zhejiang Province, Jiaxing, CHN, 314100

Website

http://www.chengdapharm.com

Chengda Pharmaceuticals Co Ltd is engaged in the research and development, production and sales of L-carnitine series products. The company mainly produces raw materials, food additives, feed additives, antibiotics, anti-cancer, anti-virus and other series of pharmaceutical intermediates. The products are sold to more than 30 countries and regions.

Chengda Pharmaceuticals Co Headlines

No Headlines